Research Article
Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma
Table 2
Treatment-related adverse events.
| | | TACE-RFA (n = 209) | TACE (n = 195) | value | | Grade 1-2/3-4 | Grade 1-2/3-4 |
| | Pain | 120/4 | 103/2 | 0.690 | | Fever (temperature >38.5°C) | 76/1 | 59/1 | 0.999 | | Vomiting | 86/10 | 70/7 | 0.804 | | Ascites | 6/1 | 6/1 | 0.999 | | Pleural effusion | 12/1 | 15/2 | 0.999 | | Bile duct stenosis | 2/0 | 1/0 | 0.999 | | Gastric hemorrhage | 2/0 | 1/1 | 0.999 | | Abdominal infection | 0/1 | 0/1 | 0.999 | | Small intestinal obstruction | 0/1 | 0/0 | 0.999 |
|
|
Data values represent the number of patients. TACE: transarterial chemoembolization; RFA: radiofrequency ablation.
|
